Skip to main content
logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.690
-0.090 (-5.06%)
At close: Jun 8, 2026, 4:00 PM EDT
1.650
-0.040 (-2.37%)
After-hours: Jun 8, 2026, 5:27 PM EDT

Pyxis Oncology Revenue

Pyxis Oncology had revenue of $13.86M in the twelve months ending March 31, 2026. In the year 2025, Pyxis Oncology had annual revenue of $13.86M, down -14.17%.

Revenue (ttm)
$13.86M
Revenue Growth
-14.17%
P/S Ratio
7.73
Revenue / Employee
$247,464
Employees
56
Market Cap
107.07M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202513.86M-2.29M-14.17%
Dec 31, 202416.15M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Black Diamond Therapeutics70.00M
Verrica Pharmaceuticals37.16M
Coya Therapeutics7.94M
Alps Group3.74M
Cardiff Oncology525.00K
NeOnc Technologies Holdings39.99K
Fractyl Health3.00K
Revenue Rankings

PYXS News

More News